CTOs on the Move

Basic Home Infusion

www.basichomeinfusion.com

 
Basic Home Infusion is a highly specialized home infusion company providing high quality and cost effective at home services since 1983. BHI is JCAHO accredited and compliant with USP standards. As one of the largest independent specialty infusion providers in the United States, BHI offers dedicated nursing and infusion services in support of the patients BHI serves. By coordinating your patients care with BHI, whatever your needs, you can be assured of our commitment to quality.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Southwestern Health

Southwestern Health Resources, which blends the strengths of University of Texas Southwestern Medical Center and Texas Health Resources, includes a network of 29 hospital locations and more than 5,000 physicians, committed to being the national leader in population health. With more than 500 points of access to care, this provides for higher value and allows patients to access services across a full continuum of medical needs. The network serves people across 17 counties in North Texas. In total, Southwestern Health coordinates care for more than 650,000 patients, aligned with commercial health care plans and Medicare programs. SWHR operates the nation`s highest rated Next Generation Accountable Care Organization for savings.

Next Breath

Next Breath is a Halethorpe, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Concentra Inc.

Concentra Managed Care, Inc. is the leading provider of healthcare management and cost containment services to the workers' compensation, auto insurance and disability insurance markets.

Bayer's A1CNow+ Headquarters

Bayer's A1CNow+ Headquarters is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gynesonics

At Gynesonics our mission is to design and develop new and advanced technologies for improving women`s health. We are focused on providing an incision-free option to women and the physicians who care for them, in treating symptomatic uterine fibroids. We are initiating a pivotal IDE trial in the United States to verify the safety and efficacy of the Sonata system, in preserving the uterus while treating those fibroids associated with abnormal uterine bleeding that are difficult to treat with existing technology and surgical techniques. We are committed to providing women with a safe and effective incision-free alternative to the invasive surgical techniques of hysterectomy or myomectomy for their severe menstrual symptoms associated with fibroids.